PATENT CLAIM ANALYSIS

Application Number: 15922468
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "019400"]

Abstract:
The present invention relates to a composition for inhibiting fibrosis and more specifically, to a composition for inhibiting fibrosis, wherein the composition is effective in inhibiting fibrosis of tissue cells by containing a peptide derived from telomerase. The peptide according to the present invention exhibits an effect of inhibiting the progression of various kinds of fibrosis, including fibrosis due to occurrence of cancer, fibrosis due to the administration of chemotherapy anticancer drugs, fibrosis due to the exposure to radiation, or progressive fibrosis of tissues, including a TGF-β signaling procedure, and thus can provide a composition for anti-fibrosis or inhibiting fibrosis and a method for treating diseases due to fibrosis.

Claim (Index 9):
The anti-fibrosis composition of  claim 1 , wherein the composition is involved in a TGF-\u03b2 signaling process to inhibit fibrosis of dermal tissue.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 2.01695
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15303370', '15576111', '14943752', '13389051', '13445759']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7038082883515778
- 35 USC 102 Novelty (BERT): 0.6184105932050817
- Combined Prediction Score: 0.6952685188369283
- Mean Citation Score: 339.00011
- Max Citation Score: 582.61536
- Similarity Product: 474.08572894506455

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test